Kroger

Joint Support Glucosamine Chondroitin Plus MSM with Univestin

C
N+ Score70
Joint & BoneServing: 3 Tablet(s)Type: Other Combinations

Kroger's Joint Support Glucosamine Chondroitin Plus MSM with Univestin is an 'Other Combinations' supplement in the Joint & Bone category, containing 7 ingredients. It scores 70, earning a 'C' grade, which denotes a good formulation. This product features 1500mg of Glucosamine Hydrochloride and 1500mg of Methylsulfonylmethane (MSM), dosages commonly used in research for joint health. Chondroitin Sulfate is included at 200mg, which is below typical clinical recommendations. The transparent label lists all active ingredients. This supplement is suitable for individuals seeking support for joint comfort and mobility, particularly benefiting from the well-dosed Glucosamine and MSM.

About This Product

Joint Support Glucosamine Chondroitin Plus MSM with Univestin by Kroger is a joint & bone supplement containing 7 active ingredients. It has earned an N+ Score of 70/100 (Grade C).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness50/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity100/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms

Weaknesses

  • −No major weaknesses identified

Ingredient Analysis (7 ingredients)

IngredientAmountDose Adequacy
Calories10.000 {Calories}N/A
Total Carbohydrates2.000 gN/A
Sodium25.000 mgN/A
Chondroitin Sulfate200.000 mgN/A
Methylsulfonylmethane1500.000 mgN/A
Glucosamine Hydrochloride1500.000 mgN/A
Proprietary Antioxidant Extract Blend250.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.